NYSTATIN AND TRIAMCINOLONE ACETONIDE

NYSTATIN AND TRIAMCINOLONE ACETONIDE was reported 105 times

These side effects are most commonly reported by patients taking NYSTATIN AND TRIAMCINOLONE ACETONIDE:

# Side effect Count
0 DRUG INEFFECTIVE 23
1 PRODUCT USE IN UNAPPROVED INDICATION 11
2 APPLICATION SITE PAIN 8
3 PRURITUS 8
4 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6
5 OFF LABEL USE 5
6 PAIN 5
7 RASH 5
8 ACCIDENTAL EXPOSURE TO PRODUCT 4
9 APPLICATION SITE PRURITUS 4
10 BURNING SENSATION 4
11 DIARRHOEA 4
12 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4
13 FATIGUE 4
14 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
15 NAUSEA 4
16 URINARY TRACT INFECTION 4
17 WEIGHT DECREASED 4
18 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4
19 APPLICATION SITE ERYTHEMA 3
20 CONDITION AGGRAVATED 3
21 EXPIRED PRODUCT ADMINISTERED 3
22 HEADACHE 3
23 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
24 INSOMNIA 3
25 JOINT SWELLING 3
26 PRODUCT CONTAINER ISSUE 3
27 PRODUCT QUALITY ISSUE 3
28 VOMITING 3
29 ABDOMINAL DISCOMFORT 2
30 APPLICATION SITE IRRITATION 2
31 BLOOD CHOLESTEROL INCREASED 2
32 BLOOD GLUCOSE INCREASED 2
33 CHEST PAIN 2
34 DEPRESSION 2
35 DIZZINESS 2
36 DRUG EFFECT DECREASED 2
37 DRY SKIN 2
38 DYSGEUSIA 2
39 ERYTHEMA 2
40 EYE IRRITATION 2
41 FUNGAL INFECTION 2
42 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
43 INCORRECT DRUG ADMINISTRATION DURATION 2
44 INTENTIONAL PRODUCT USE ISSUE 2
45 KIDNEY INFECTION 2
46 MALAISE 2
47 MUSCLE SPASMS 2
48 NO ADVERSE EVENT 2
49 PERIPHERAL SWELLING 2
50 PRODUCT DISPENSING ERROR 2
51 PRODUCT PHYSICAL CONSISTENCY ISSUE 2
52 RASH ERYTHEMATOUS 2
53 SKIN EXFOLIATION 2
54 SKIN IRRITATION 2
55 SWELLING FACE 2
56 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
57 THERAPEUTIC RESPONSE UNEXPECTED 2
58 ABDOMINAL PAIN 1
59 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1
60 ACTIVITIES OF DAILY LIVING IMPAIRED 1
61 ACUTE MYOCARDIAL INFARCTION 1
62 AFFECT LABILITY 1
63 AGITATION 1
64 ALANINE AMINOTRANSFERASE INCREASED 1
65 ALBUMIN GLOBULIN RATIO DECREASED 1
66 ALLERGIC REACTION TO EXCIPIENT 1
67 ANAEMIA 1
68 ANAPHYLACTIC REACTION 1
69 ANORECTAL DISCOMFORT 1
70 ANTISOCIAL BEHAVIOUR 1
71 APPLICATION SITE DISCOLOURATION 1
72 APPLICATION SITE HAEMORRHAGE 1
73 APPLICATION SITE RASH 1
74 APPLICATION SITE VESICLES 1
75 ASPARTATE AMINOTRANSFERASE INCREASED 1
76 ASTHENIA 1
77 ATRIAL FIBRILLATION 1
78 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 1
79 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1
80 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
81 BACK PAIN 1
82 BACTERIAL TEST POSITIVE 1
83 BACTERIAL VAGINOSIS 1
84 BLOOD ALBUMIN DECREASED 1
85 BLOOD BILIRUBIN INCREASED 1
86 BLOOD CHLORIDE INCREASED 1
87 BLOOD CREATININE DECREASED 1
88 BLOOD GLUCOSE DECREASED 1
89 BLOOD IRON INCREASED 1
90 BLOOD LACTATE DEHYDROGENASE INCREASED 1
91 BLOOD LACTIC ACID INCREASED 1
92 BLOOD POTASSIUM DECREASED 1
93 BLOOD POTASSIUM INCREASED 1
94 BLOOD PRESSURE ABNORMAL 1
95 BLOOD PRESSURE INCREASED 1
96 BLOOD UREA INCREASED 1
97 BLOOD URINE PRESENT 1
98 BORDERLINE GLAUCOMA 1
99 BREAST TENDERNESS 1
100 BRONCHIAL HYPERACTIVITY 1
101 C-REACTIVE PROTEIN INCREASED 1
102 CARBON DIOXIDE DECREASED 1
103 CARDIAC FAILURE CONGESTIVE 1
104 CARDIO-RESPIRATORY ARREST 1
105 CARDIOMYOPATHY 1
106 CEREBROVASCULAR ACCIDENT 1
107 CERVIX CARCINOMA 1
108 CHEILITIS 1
109 CHILLS 1
110 CHROMATURIA 1
111 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
112 COGNITIVE DISORDER 1
113 CONFUSIONAL STATE 1
114 CONSTIPATION 1
115 CONTRACEPTION 1
116 CONTRAINDICATED PRODUCT ADMINISTERED 1
117 CORONARY ARTERY DISEASE 1
118 COVID-19 1
119 CSF CELL COUNT INCREASED 1
120 CSF TEST ABNORMAL 1
121 CULTURE URINE POSITIVE 1
122 CYSTITIS 1
123 DECUBITUS ULCER 1
124 DELIRIUM 1
125 DERMATITIS 1
126 DERMATITIS ALLERGIC 1
127 DERMATITIS ATOPIC 1
128 DISEASE RECURRENCE 1
129 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1
130 DRUG INTERACTION 1
131 DRUG PRESCRIBING ERROR 1
132 DYSARTHRIA 1
133 DYSPHAGIA 1
134 DYSPHONIA 1
135 DYSPNOEA 1
136 ECZEMA 1
137 ENTEROBACTER PNEUMONIA 1
138 EOSINOPHIL PERCENTAGE DECREASED 1
139 EOSINOPHIL PERCENTAGE INCREASED 1
140 EYE PAIN 1
141 FEELING ABNORMAL 1
142 FLATULENCE 1
143 FREQUENT BOWEL MOVEMENTS 1
144 GAIT DISTURBANCE 1
145 GASTROINTESTINAL PAIN 1
146 GENITAL INJURY 1
147 GROIN PAIN 1
148 HAEMATOCRIT DECREASED 1
149 HAEMOGLOBIN ABNORMAL 1
150 HAEMOLYSIS 1
151 HAEMORRHAGE 1
152 HAEMOTHORAX 1
153 HAPTOGLOBIN DECREASED 1
154 HEAD DISCOMFORT 1
155 HYPOACUSIS 1
156 HYPOAESTHESIA 1
157 HYPOKALAEMIA 1
158 HYPONATRAEMIA 1
159 ILLNESS 1
160 IMMUNODEFICIENCY 1
161 INCORRECT DOSE ADMINISTERED 1
162 INCORRECT PRODUCT ADMINISTRATION DURATION 1
163 INCORRECT PRODUCT STORAGE 1
164 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
165 INFECTION 1
166 INFLAMMATION 1
167 INFLUENZA 1
168 LIMB INJURY 1
169 LIP DRY 1
170 LIP EXFOLIATION 1
171 LOSS OF LIBIDO 1
172 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
173 LYMPHOCYTE COUNT DECREASED 1
174 LYMPHOCYTE PERCENTAGE DECREASED 1
175 LYMPHOMA 1
176 MEAN CELL HAEMOGLOBIN DECREASED 1
177 MEAN PLATELET VOLUME DECREASED 1
178 MEDIASTINAL INFECTION 1
179 MEDICATION ERROR 1
180 MENSTRUATION IRREGULAR 1
181 MIDDLE EAR EFFUSION 1
182 MIGRAINE 1
183 MITRAL VALVE INCOMPETENCE 1
184 MONOCYTE COUNT DECREASED 1
185 MONOCYTE PERCENTAGE INCREASED 1
186 MUSCLE SPASTICITY 1
187 MYOCARDIAL ISCHAEMIA 1
188 NEPHROLITHIASIS 1
189 NEURALGIA 1
190 NEUROGENIC BLADDER 1
191 NEUTROPHIL COUNT INCREASED 1
192 NEUTROPHIL PERCENTAGE INCREASED 1
193 NITRITE URINE PRESENT 1
194 NUCLEATED RED CELLS 1
195 OEDEMA PERIPHERAL 1
196 ONYCHOMYCOSIS 1
197 OPEN ANGLE GLAUCOMA 1
198 OROPHARYNGEAL PAIN 1
199 OSTEOPENIA 1
200 OSTEOPOROSIS 1
201 OVARIAN CYST 1
202 OVARIAN CYST RUPTURED 1
203 PAIN IN JAW 1
204 PAINFUL ERECTION 1
205 PARAPLEGIA 1
206 PENILE PAIN 1
207 PERFUME SENSITIVITY 1
208 PLANTAR FASCIITIS 1
209 PLATELET COUNT INCREASED 1
210 PLEURAL EFFUSION 1
211 PNEUMONIA 1
212 PNEUMONIA KLEBSIELLA 1
213 POLYCHROMASIA 1
214 POOR QUALITY PRODUCT ADMINISTERED 1
215 POST THROMBOTIC SYNDROME 1
216 POSTURING 1
217 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
218 PRODUCT ADMINISTRATION ERROR 1
219 PRODUCT CLOSURE ISSUE 1
220 PRODUCT DESIGN ISSUE 1
221 PRODUCT DOSE OMISSION 1
222 PRODUCT LABEL ISSUE 1
223 PRODUCT PACKAGING DIFFICULT TO OPEN 1
224 PRODUCT PRESCRIBING ISSUE 1
225 PRODUCT SELECTION ERROR 1
226 PRODUCT STORAGE ISSUE 1
227 PRODUCT SUBSTITUTION ISSUE 1
228 PROTEIN URINE PRESENT 1
229 PROTHROMBIN TIME PROLONGED 1
230 PYELONEPHRITIS 1
231 PYREXIA 1
232 RADICULOPATHY 1
233 RED BLOOD CELL COUNT DECREASED 1
234 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
235 RED BLOOD CELLS URINE POSITIVE 1
236 RED CELL DISTRIBUTION WIDTH INCREASED 1
237 RENAL FAILURE 1
238 RETICULOCYTE COUNT INCREASED 1
239 RETICULOCYTE PERCENTAGE INCREASED 1
240 RHINITIS ALLERGIC 1
241 ROTATOR CUFF SYNDROME 1
242 SERUM FERRITIN INCREASED 1
243 SINUSITIS 1
244 SKIN ABRASION 1
245 SKIN CANCER 1
246 SKIN DISORDER 1
247 SKIN FISSURES 1
248 SKIN LACERATION 1
249 STEROID WITHDRAWAL SYNDROME 1
250 STICKY SKIN 1
251 SUPRAVENTRICULAR EXTRASYSTOLES 1
252 SUPRAVENTRICULAR TACHYCARDIA 1
253 SUSPECTED PRODUCT CONTAMINATION 1
254 SYNCOPE 1
255 THERAPEUTIC PRODUCT EFFECT INCREASED 1
256 THERAPY INTERRUPTED 1
257 TINEA CRURIS 1
258 TOOTHACHE 1
259 TRANSFERRIN SATURATION INCREASED 1
260 TRANSIENT ISCHAEMIC ATTACK 1
261 TREMOR 1
262 URINARY CASTS 1
263 URINARY INCONTINENCE 1
264 URINARY SEDIMENT PRESENT 1
265 URINE ANALYSIS ABNORMAL 1
266 URINE LEUKOCYTE ESTERASE POSITIVE 1
267 UROBILINOGEN URINE INCREASED 1
268 UTERINE HAEMORRHAGE 1
269 VAGINAL DISCHARGE 1
270 VAGINAL INFECTION 1
271 VASCULAR INSUFFICIENCY 1
272 VISION BLURRED 1
273 VITAMIN C ABNORMAL 1
274 VITAMIN D DEFICIENCY 1
275 VULVAL DISORDER 1
276 VULVOVAGINAL CANDIDIASIS 1
277 VULVOVAGINAL PAIN 1
278 VULVOVAGINAL PRURITUS 1
279 WEIGHT INCREASED 1
280 WHITE BLOOD CELLS URINE POSITIVE 1
281 WOUND 1
282 WRONG DRUG ADMINISTERED 1
283 WRONG PRODUCT ADMINISTERED 1